Spontaneous proximal deep vein thrombosis in a patient with severe haemophilia A.
暂无分享,去创建一个
[1] Z. Berneman,et al. Distal deep venous thrombosis in a hemophilia A patient with inhibitor and severe infectious disease, 18 days after recombinant activated factor VII transfusion. , 2002, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.
[2] M. Baiget,et al. Modifier genes in haemophilia: their expansion in the human genome , 2002, Haemophilia : the official journal of the World Federation of Hemophilia.
[3] S. Claster,et al. von Willebrand factor‐cleaving protease inhibitor in a patient with human immunodeficiency syndrome‐associated thrombotic thrombocytopenic purpura , 2002, British journal of haematology.
[4] V. De Stefano,et al. Recurrent venous thrombosis in a patient with haemophilia A and HIV infection. , 2002, Haematologica.
[5] M. Saif,et al. AIDS and thrombosis: retrospective study of 131 HIV-infected patients. , 2001, AIDS Patients Care and STDs.
[6] Y. Shoenfeld,et al. Antiphospholipid syndrome induced by HIV , 2001, Lupus.
[7] M. Saif,et al. HIV and thrombosis: a review. , 2001, AIDS patient care and STDs.
[8] W. Lewis. Atherosclerosis in AIDS: potential pathogenetic roles of antiretroviral therapy and HIV. , 2000, Journal of molecular and cellular cardiology.
[9] J. Heit,et al. Venous thromboembolism after hip fracture surgery in a patient with haemophilia B and factor V Arg506Gln (factor V Leiden) , 2000, Haemophilia : the official journal of the World Federation of Hemophilia.
[10] C. Esmon. Does Inflammation Contribute to Thrombotic Events? , 2000, Pathophysiology of Haemostasis and Thrombosis.
[11] B. Ritchie,et al. Effect of the Factor V Leiden Mutation on the Clinical Expression of Severe Hemophilia A , 2000, Thrombosis and Haemostasis.
[12] Allan,et al. Thrombosis in a duplicated superficial femoral vein in a patient with haemophilia A , 2000, Haemophilia : the official journal of the World Federation of Hemophilia.
[13] W. Kreuz,et al. Portal vein thrombosis in a patient with severe haemophilia A and F V G1691A mutation during continuous infusion of F VIII after intramural jejunal bleeding – Successful thrombolysis under heparin therapy , 1999, European Journal of Pediatrics.
[14] J. Vermylen,et al. Acute Myocardial Infarction Following Administration of Recombinant Activated Factor VII (Novo Seven) in a Patient with Haemophilia A and Inhibitor , 1999, Thrombosis and Haemostasis.
[15] M. Köhler. Thrombogenicity of prothrombin complex concentrates. , 1999, Thrombosis research.
[16] D. Cooper,et al. Portal vein thrombosis in patients receiving indinavir, an HIV protease inhibitor. , 1997, AIDS.
[17] A. Blann,et al. Soluble Adhesion Molecules and Endothelial Cell Damage in HIV Infected Patients , 1997, Thrombosis and Haemostasis.
[18] C. Négrier,et al. Combined factor IX and protein C deficiency in a child: Thrombogenic effects of two factor IX concentrates , 1995, American journal of hematology.
[19] B. Evatt,et al. Protein S deficiency in men with long-term human immunodeficiency virus infection. , 1993, Blood.
[20] M. Poon,et al. Deep venous thrombosis in hemophilia A. , 1992, The American journal of medicine.
[21] C. Tamalet,et al. Endothelial cell dysfunction in HIV infection. , 1992, Journal of acquired immune deficiency syndromes.